NewsBenzinga엔카르타, 진행 중인 Ntrust 임상 시험 프로그램에서 NKX019로 치료받은 40명의 환자에 대한 통합 안전성 결과 발표···동종, 즉시 사용 가능한 CD19 표적 CAR NK 세포 치료제 후보 엔카르타, 진행 중인 Ntrust 임상 시험 프로그램에서 NKX019로 치료받은 40명의 환자에 대한 통합 안전성 결과 발표···동종, 즉시 사용 가능한 CD19 표적 CAR NK 세포 치료제 후보 Benzinga 2026.11.11 12:03 (GMT+0) Open on Benzinga Other news Airbnb Co-Founder Joe Gebbia Says He Modernized Federal Retirement System In 6 Months for $1.5 Million After Contractors Spent $100 Million NVIDIA's Jensen Huang Crisis Threatens to Rewrite the Rules of the AI Boom Mondelez's Multi-Million Portfolio Shift: Unloads French Bakery and Cereal Bars Business Ur-Energy Begins Fieldwork For Baseline Studies At Its Lost Solider Project; Will Take Construction Decision For Potential Third Mine After Technical Report Alibaba Is Facing a Perfect Storm, and Q2 Earnings Won’t Be a Magical Fix for BABA Stock CME Stock: Is Wall Street Bullish or Bearish?
Airbnb Co-Founder Joe Gebbia Says He Modernized Federal Retirement System In 6 Months for $1.5 Million After Contractors Spent $100 Million
Ur-Energy Begins Fieldwork For Baseline Studies At Its Lost Solider Project; Will Take Construction Decision For Potential Third Mine After Technical Report